Tumour-associated macrophages enhance breast cancer malignancy via inducing ZEB1-mediated DNMT1 transcriptional activation.
Zhongwei LiPengfei WangWenjie CuiHongmei YongDiandian WangTiesuo ZhaoWenwen WangMing ShiJun-Nian ZhengJin BaiPublished in: Cell & bioscience (2022)
Our study indicates that DNMT1 is necessary for TAM-mediated breast cancer metastasis. Decitabine (DAC), as a specific DNA methylation inhibitor and FDA-approved drug, is a bona fide drug for breast cancer treatment.